Examination of the effect of renal protection of aliskiren in chronic renal failure patient with hypertension (preservation period).

Trial Profile

Examination of the effect of renal protection of aliskiren in chronic renal failure patient with hypertension (preservation period).

Completed
Phase of Trial: Phase III

Latest Information Update: 13 May 2016

At a glance

  • Drugs Aliskiren (Primary)
  • Indications Hypertension
  • Focus Pharmacodynamics; Registrational
  • Acronyms ERA-CRF HT
  • Most Recent Events

    • 10 Sep 2015 Status changed from recruiting to completed, as reported by University Hospital Medical Information Network - Japan.
    • 26 Mar 2011 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan record.
    • 06 Oct 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top